• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Drug information and prescription for older adults

Research Project

Project/Area Number 17K08919
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Medical sociology
Research InstitutionKagawa University

Principal Investigator

Ikeda Masayuki  香川大学, 医学部, 客員研究員 (10242215)

Co-Investigator(Kenkyū-buntansha) 嶋澤 るみ子  東海大学, 医学部, 教授 (00411083)
Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywordsレギュラトリーサイエンス / 高齢者 / 市販後安全性 / 承認審査 / 国際比較研究 / 医薬品評価学 / レギュラトリー・サイエンス / 医薬品情報 / ドラッグ・ラグ / 高齢化 / 市販後調査 / 国際比較
Outline of Final Research Achievements

The aging of Japanese population is progressing fastest in the world. Aging affects the benefit-risk balance of medicines from various aspects, e.g. behavioral problems such as decreased adherence and functional deterioration of organs. The aim of our study was to contribute the improvement of the benefit- risk balance of drug use in the elderly. For this purpose, we investigated how, when, and from what perspective information was collected, and in what form information was used regarding the drug use of the elderly.

Academic Significance and Societal Importance of the Research Achievements

本研究の成果は、既に添付文書の国際比較研究の実績を有する申請者が、そのデータと経験を活用し、これまで手をつけられていなかった高齢者への投与に関する情報提供に関して、日米欧の国際比較を行うと同時に、提供されている高齢者関連情報の根拠[収集時期、方法(臨床試験、市販後自発報告等)]を、当該医薬品の承認申請資料や市販後規制当局発出資料での高齢者関連情報まで検討して明らかにすることにより、それぞれの時期・方法で収集された情報の特性を分析し、高齢者関連情報収集と提供に影響した因子を明らかにした点にある。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (8 results)

All 2019 2018 2017

All Journal Article (6 results) (of which Peer Reviewed: 6 results,  Open Access: 4 results,  Acknowledgement Compliant: 1 results) Book (2 results)

  • [Journal Article] Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.2019

    • Author(s)
      Shimazawa R, Ikeda M.
    • Journal Title

      J Pharm Policy Pract

      Volume: 12 Issue: 1 Pages: 30-30

    • DOI

      10.1186/s40545-019-0193-y

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus2019

    • Author(s)
      Ikeda Masayuki、Shimazawa Rumiko
    • Journal Title

      Journal of General and Family Medicine

      Volume: 20 Issue: 4 Pages: 1-10

    • DOI

      10.1002/jgf2.244

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Pharmacogenomic biomarkers on drug labels: interpretation of United States and Japanese labels based on Pharmacogenetics Knowledgebase2018

    • Author(s)
      Shimazawa R., Ikeda M.
    • Journal Title

      Journal of Clinical Pharmacy and Therapeutics

      Volume: 印刷中 Issue: 4 Pages: 500-506

    • DOI

      10.1111/jcpt.12692

    • Related Report
      2018 Research-status Report
    • Peer Reviewed
  • [Journal Article] Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials2018

    • Author(s)
      Shimazawa R, Kano Y, Ikeda M
    • Journal Title

      Pharmacol Res Perspect

      Volume: 6 Issue: 6

    • DOI

      10.1002/prp2.435

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of Risk-Benefit Perception and Trust on Medical Technology Acceptance in Relation to Drug and Device Lag A Tripartite Cross-Sectional Survey2017

    • Author(s)
      Todaka K, Kishimoto J, Ikeda M, Ikeda K, Yamamoto H.
    • Journal Title

      Ther Innov Regul Sci

      Volume: - Issue: 5 Pages: 629-640

    • DOI

      10.1177/2168479017739267

    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Journal Article] Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study2017

    • Author(s)
      Shimazawa R, Ikeda M
    • Journal Title

      Journal of Pharmaceutical Policy and Practice

      Volume: 10 Issue: 1 Pages: 4-4

    • DOI

      10.1186/s40545-016-0094-2

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Book] Chapter 9. Clinical Trial Designs for Testing Companion Diagnostics. In: Il-Jin Kim, ed. Companion Diagnostics (CDx) in Precision Medicine.2019

    • Author(s)
      Shimazawa R, Ikeda M.
    • Total Pages
      270
    • Publisher
      Jenny Stanford Publishing
    • ISBN
      9780429275906
    • Related Report
      2019 Annual Research Report
  • [Book] Chapter 19. Regulatory requirements for companion diagnostics -Japan. In: Jan Trost Jorgensen, eds. Companion and Complementary Diagnostics From Biomarker Discovery to Clinical Implementation. 1st ed.2019

    • Author(s)
      Shimazawa R, Ikeda M.
    • Total Pages
      508
    • Publisher
      Academic Press
    • ISBN
      9780128135396
    • Related Report
      2019 Annual Research Report

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi